Alaska Department of Revenue Cuts Stake in Alnylam Pharmaceuticals by Over Half
🌧️Trending News Alnylam Pharmaceuticals ($NASDAQ:ALNY) is a biopharmaceutical company that focuses on the development of RNA interference (RNAi) therapeutics. The [...]
Alnylam Pharmaceuticals Intrinsic Stock Value – Hedge Funds Show Confidence in Alnylam Pharmaceuticals as Aggressive Growth Stock
☀️Trending News Alnylam Pharmaceuticals ($NASDAQ:ALNY), Inc. is a biopharmaceutical company that focuses on developing innovative RNA interference (RNAi) therapeutics. With [...]
Alnylam Pharmaceuticals Stock Intrinsic Value – The Medicines Company Strikes Deal with Alnylam Pharmaceuticals for Revolutionary Cholesterol Treatment Program
🌧️Trending News ALNYLAM PHARMACEUTICALS ($NASDAQ:ALNY) is a leading biopharmaceutical company that focuses on developing innovative RNA interference (RNAi) therapeutics. Their [...]
Alnylam Pharmaceuticals Sees Disproportionate Price Despite Revenues
🌥️Trending News Alnylam Pharmaceuticals ($NASDAQ:ALNY), Inc. is a biopharmaceutical company based in Cambridge, Massachusetts that specializes in the development of [...]
RNAi Technology to Propel ALNYLAM PHARMACEUTICALS’ Growth from 2023 to 2029
☀️Trending News ALNYLAM PHARMACEUTICALS ($NASDAQ:ALNY) is a biopharmaceutical company developing innovative medicines based on ribonucleic acid interference (RNAi) technology. ALNYLAM [...]
Principal Financial Group Increases Stake in Alnylam Pharmaceuticals,
🌥️Trending News Principal Financial Group Inc. has recently increased its stake in Alnylam Pharmaceuticals ($NASDAQ:ALNY), Inc., indicating a strong vote [...]
ALNYLAM PHARMACEUTICALS Reports Q2 2023 Earnings Results on June 30, 2023
🌥️Earnings Overview On June 30, 2023, ALNYLAM PHARMACEUTICALS ($NASDAQ:ALNY) announced its financial results for the second quarter of 2023. This [...]
ALNYLAM PHARMACEUTICALS Reports Q2 FY2023 Earnings Results on August 3 2023
🌥️Earnings Overview Alnylam Pharmaceuticals ($NASDAQ:ALNY) reported their financial results for the second quarter of the fiscal year 2023 (ending on [...]
Alnylam Pharmaceuticals: Strong Q2 Earnings Call Ahead Amidst Neutral Financial Sentiment
☀️Introduction: Alnylam Pharmaceuticals is all set to announce its highly anticipated second-quarter earnings report on August 3rd, 2023, at 8:30 [...]
Alnylam Pharmaceuticals Leads the Way in Transthyretin Amyloidosis Market by 2023
🌥️Trending News Alnylam Pharmaceuticals ($NASDAQ:ALNY) is a leading biopharmaceutical company pioneering novel medicines based on RNA interference (RNAi) therapeutics. Through [...]
